IQVIA Cash Flow Statement
NYSE: IQVHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
At close: Oct 9, 4:02 PM ET · Delayed 15 min
IQVIA free cash flow
In fiscal 2025, IQVIA generated $2.65 billion of operating cash flow and spent $603.0 million on capital expenditures. That left free cash flow of $2.05 billion, a free-cash-flow margin of 12.6% of revenue. Free cash flow was down 3.0% from the prior year's $2.11 billion.
IQVIA returned $1.24 billion to shareholders through share repurchases, equal to 61% of free cash flow.
Summary generated from market data by MetaCap's automated system. Methodology
IQVIA cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 1.36B | 1.37B | 1.36B | 1.09B | 971.00M | 308.00M | 227.00M | 284.00M | 1.30B | 87.00M |
| Net Income growth (YoY) | -0.87% | +1.10% | +24.47% | +12.36% | +215.26% | +35.68% | -20.07% | -78.09% | +1389.66% | -77.58% |
| Depreciation & Amortization | 1.14B | 1.11B | 1.13B | 1.13B | 1.26B | 1.29B | 1.20B | 1.14B | 1.01B | 289.00M |
| Stock-Based Compensation | 247.00M | 206.00M | 217.00M | 194.00M | 170.00M | 95.00M | 146.00M | 113.00M | 106.00M | 106.00M |
| Change in Working Capital | 521.00M | 284.00M | -85.00M | -15.00M | 664.00M | 600.00M | 33.00M | 27.00M | -209.00M | 27.00M |
| Operating Cash Flow | 2.65B | 2.72B | 2.15B | 2.26B | 2.94B | 1.96B | 1.42B | 1.25B | 970.00M | 860.00M |
| Capital Expenditures | -603.00M | -602.00M | -649.00M | -674.00M | -640.00M | -616.00M | -582.00M | -459.00M | -369.00M | -164.00M |
| Investing Cash Flow | -2.31B | -1.44B | -1.60B | -2.01B | -2.10B | -796.00M | -1.19B | -810.00M | -1.19B | 1.73B |
| Share Repurchases | -1.24B | -1.35B | -992.00M | -1.17B | -406.00M | -447.00M | -949.00M | -1.41B | -2.62B | -1.10B |
| Debt Issued | 6.46B | 0 | 4.00B | 1.25B | 1.95B | 1.59B | 1.90B | 1.63B | 5.24B | 466.00M |
| Debt Repaid | -5.19B | -172.00M | -2.87B | -634.00M | -2.09B | -864.00M | -899.00M | -732.00M | -2.88B | -1.95B |
| Financing Cash Flow | -150.00M | -878.00M | -382.00M | -329.00M | -1.24B | -217.00M | -276.00M | -452.00M | -72.00M | -2.28B |
| Net Change in Cash | 278.00M | 326.00M | 160.00M | -150.00M | -448.00M | 977.00M | -54.00M | -68.00M | -239.00M | 221.00M |
| Free Cash Flow | 2.05B | 2.11B | 1.50B | 1.59B | 2.30B | 1.34B | 835.00M | 795.00M | 601.00M | 696.00M |
This table shows 10 annual periods of IQVIA's cash flow statement, from FY 2025 back to FY 2016, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow IQV's reporting calendar. What is a cash flow statement?